Anna Mudge - October 29, 2024 GENE-ius options to protect gene therapies Gene therapies involve treating patients by manipulating their genetic makeup. Such therapies may ...
Adam Gregory - August 13, 2024 ‘It’s a 50% reduction in ageing’ Singapore startup VVB Bio promises a dramatic reduction in ageing via a single jab. Now out of ...
Katherine Collins - April 2, 2024 Efficiency in Expansion: Meeting the Scale-Up Challenge in Cell and Gene Therapies One of the pivotal challenges in the development and commercialisation of cell and gene therapies ...
Katie Dale - February 26, 2024 Top marks for Iovance as FDA approves first-in-class cell therapy Amtagvi for solid tumours On February 16, 2024, a real milestone was reached in the cell therapy field, as the FDA approved ...
Edward Couchman - February 7, 2024 Genes as Medicines: Treating the Untreatable In 2023, gene therapy hit the headlines in the UK, when the BBC reported the cure of a toddler with ...
Alex Galbraith - November 17, 2023 The first CRISPR treatment – Casgevy wins UK approval for sickle cell disease In a world first, the UK medicines regulator has given the green light to a therapy employing ...
Alex Galbraith - September 1, 2023 Gene therapy – the status quo and future trends The uptick in recent approvals in the gene therapy space is emblematic of a field which is now ...
Fay Allen - August 10, 2023 In vivo expression of chimeric antigen receptors: using gene therapy to improve cell therapy In vivo CAR therapies build on the success of standard CAR treatments and aim to overcome the ...
Edward Couchman - August 7, 2023 Cells as medicines: the promise of cell therapy Cell therapy is one of the most exciting areas of medical science, with recent years having seen ...
Nick Sutcliffe - July 26, 2023 IP priorities for forward-looking cell and gene therapy businesses IP priorities are especially important to businesses developing advanced therapeutic products. ...
